annual CAPEX:
$3.81B+$1.06B(+38.54%)Summary
- As of today (April 23, 2025), NVS annual capital expenditures is $3.81 billion, with the most recent change of +$1.06 billion (+38.54%) on December 31, 2024.
- During the last 3 years, NVS annual CAPEX has risen by +$1.26 billion (+49.22%).
- NVS annual CAPEX is now at all-time high.
Performance
NVS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$1.13B+$332.00M(+41.55%)Summary
- As of today (April 23, 2025), NVS quarterly capital expenditures is $1.13 billion, with the most recent change of +$332.00 million (+41.55%) on December 31, 2024.
- Over the past year, NVS quarterly CAPEX has increased by +$403.00 million (+55.36%).
- NVS quarterly CAPEX is now -15.47% below its all-time high of $1.34 billion, reached on December 31, 2007.
Performance
NVS quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$3.81B+$348.00M(+10.04%)Summary
- As of today (April 23, 2025), NVS TTM capital expenditures is $3.81 billion, with the most recent change of +$348.00 million (+10.04%) on December 31, 2024.
- Over the past year, NVS TTM CAPEX has increased by +$464.00 million (+13.85%).
- NVS TTM CAPEX is now at all-time high.
Performance
NVS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.5% | +55.4% | +13.8% |
| 3 y3 years | +49.2% | +278.3% | +65.6% |
| 5 y5 years | +69.0% | +150.2% | +78.8% |
NVS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.3% | -2.2% | +278.3% | at high | +115.6% |
| 5 y | 5-year | at high | +70.3% | -2.2% | +278.3% | at high | +115.6% |
| alltime | all time | at high | +355.1% | -15.5% | +416.4% | at high | +1641.5% |
Novartis AG CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.81B(+38.5%) | $1.13B(+41.6%) | $3.81B(+10.0%) |
| Sep 2024 | - | $799.00M(+9.8%) | $3.47B(+3.5%) |
| Jun 2024 | - | $728.00M(-37.0%) | $3.35B(-4.8%) |
| Mar 2024 | - | $1.16B(+47.6%) | $3.52B(+27.9%) |
| Dec 2023 | $2.75B(+23.0%) | $783.00M(+14.6%) | $2.75B(+11.5%) |
| Sep 2023 | - | $683.00M(-23.9%) | $2.47B(+18.4%) |
| Jun 2023 | - | $898.00M(+130.8%) | $2.08B(+17.8%) |
| Mar 2023 | - | $389.00M(-21.9%) | $1.77B(-21.0%) |
| Dec 2022 | $2.24B(-12.4%) | $498.00M(+66.6%) | $2.24B(-2.8%) |
| Sep 2022 | - | $299.00M(-48.7%) | $2.30B(-9.4%) |
| Jun 2022 | - | $583.00M(-32.1%) | $2.54B(-0.5%) |
| Mar 2022 | - | $859.00M(+52.8%) | $2.56B(+0.0%) |
| Dec 2021 | $2.56B(-1.1%) | $562.00M(+4.3%) | $2.56B(-15.3%) |
| Sep 2021 | - | $539.00M(-9.7%) | $3.02B(-2.8%) |
| Jun 2021 | - | $597.00M(-30.4%) | $3.10B(+4.9%) |
| Mar 2021 | - | $858.00M(-16.1%) | $2.96B(+14.5%) |
| Dec 2020 | $2.58B(+14.5%) | $1.02B(+63.2%) | $2.58B(+17.6%) |
| Sep 2020 | - | $627.00M(+38.7%) | $2.20B(+3.0%) |
| Jun 2020 | - | $452.00M(-6.4%) | $2.13B(+0.6%) |
| Mar 2020 | - | $483.00M(-24.1%) | $2.12B(-6.0%) |
| Dec 2019 | $2.26B(-14.8%) | $636.00M(+13.2%) | $2.26B(-0.6%) |
| Sep 2019 | - | $562.00M(+27.7%) | $2.27B(-10.9%) |
| Jun 2019 | - | $440.00M(-28.9%) | $2.55B(-1.7%) |
| Mar 2019 | - | $619.00M(-4.8%) | $2.59B(-2.1%) |
| Dec 2018 | $2.65B(+15.4%) | $650.00M(-22.7%) | $2.65B(+5.2%) |
| Sep 2018 | - | $841.00M(+74.1%) | $2.52B(+7.3%) |
| Jun 2018 | - | $483.00M(-28.3%) | $2.34B(-2.9%) |
| Mar 2018 | - | $674.00M(+30.1%) | $2.41B(+5.2%) |
| Dec 2017 | $2.29B(-20.3%) | $518.00M(-22.6%) | $2.29B(-10.3%) |
| Sep 2017 | - | $669.00M(+21.0%) | $2.56B(-1.7%) |
| Jun 2017 | - | $553.00M(-0.2%) | $2.60B(-4.5%) |
| Mar 2017 | - | $554.00M(-29.1%) | $2.72B(-5.4%) |
| Dec 2016 | $2.88B(-17.9%) | $781.00M(+9.4%) | $2.88B(-6.1%) |
| Sep 2016 | - | $714.00M(+5.8%) | $3.07B(-2.1%) |
| Jun 2016 | - | $675.00M(-4.8%) | $3.13B(-10.5%) |
| Mar 2016 | - | $709.00M(-26.8%) | $3.50B(-0.2%) |
| Dec 2015 | $3.50B(+3.0%) | $968.00M(+24.1%) | $3.50B(+3.9%) |
| Sep 2015 | - | $780.00M(-25.1%) | $3.37B(-6.1%) |
| Jun 2015 | - | $1.04B(+45.7%) | $3.59B(+2.3%) |
| Mar 2015 | - | $715.00M(-14.4%) | $3.51B(+3.1%) |
| Dec 2014 | $3.40B(+0.8%) | $835.00M(-16.4%) | $3.40B(-6.6%) |
| Sep 2014 | - | $999.00M(+3.8%) | $3.65B(+3.4%) |
| Jun 2014 | - | $962.00M(+58.2%) | $3.52B(+5.7%) |
| Mar 2014 | - | $608.00M(-43.5%) | $3.34B(-1.2%) |
| Dec 2013 | $3.38B | $1.08B(+22.4%) | $3.38B(+13.3%) |
| Sep 2013 | - | $879.00M(+13.7%) | $2.98B(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $773.00M(+18.9%) | $2.86B(+2.1%) |
| Mar 2013 | - | $650.00M(-4.3%) | $2.80B(+0.9%) |
| Dec 2012 | $2.77B(+16.1%) | $679.00M(-10.1%) | $2.77B(+0.2%) |
| Sep 2012 | - | $755.00M(+5.7%) | $2.77B(+6.6%) |
| Jun 2012 | - | $714.00M(+14.4%) | $2.60B(+3.6%) |
| Mar 2012 | - | $624.00M(-7.3%) | $2.50B(+4.9%) |
| Dec 2011 | $2.39B(+6.9%) | $673.00M(+15.2%) | $2.39B(-2.9%) |
| Sep 2011 | - | $584.00M(-6.4%) | $2.46B(+8.5%) |
| Jun 2011 | - | $624.00M(+23.3%) | $2.27B(-1.0%) |
| Mar 2011 | - | $506.00M(-32.0%) | $2.29B(+2.6%) |
| Dec 2010 | $2.23B(-18.3%) | $744.00M(+89.8%) | $2.23B(-10.1%) |
| Sep 2010 | - | $392.00M(-39.5%) | $2.48B(-4.8%) |
| Jun 2010 | - | $648.00M(+44.6%) | $2.61B(-2.7%) |
| Mar 2010 | - | $448.00M(-54.9%) | $2.68B(-2.0%) |
| Dec 2009 | $2.73B(+18.0%) | $994.00M(+92.6%) | $2.73B(+17.1%) |
| Sep 2009 | - | $516.00M(-28.2%) | $2.33B(-3.0%) |
| Jun 2009 | - | $719.00M(+42.7%) | $2.41B(-0.5%) |
| Mar 2009 | - | $504.00M(-15.3%) | $2.42B(+4.4%) |
| Dec 2008 | $2.32B(-26.1%) | $595.00M(+1.2%) | $2.32B(-24.3%) |
| Sep 2008 | - | $588.00M(-19.5%) | $3.06B(-2.0%) |
| Jun 2008 | - | $730.00M(+81.1%) | $3.12B(+3.6%) |
| Mar 2008 | - | $403.00M(-69.9%) | $3.01B(-3.8%) |
| Dec 2007 | $3.13B(+40.5%) | $1.34B(+105.8%) | $3.13B(+7.7%) |
| Sep 2007 | - | $650.00M(+4.3%) | $2.91B(+6.4%) |
| Jun 2007 | - | $623.00M(+19.3%) | $2.73B(+11.6%) |
| Mar 2007 | - | $522.00M(-53.1%) | $2.45B(+9.9%) |
| Dec 2006 | $2.23B(+61.6%) | $1.11B(+133.8%) | $2.23B(+29.1%) |
| Sep 2006 | - | $476.00M(+40.4%) | $1.73B(+12.4%) |
| Jun 2006 | - | $339.00M(+12.3%) | $1.54B(+5.2%) |
| Mar 2006 | - | $302.00M(-50.5%) | $1.46B(+5.8%) |
| Dec 2005 | $1.38B(-4.1%) | $610.00M(+114.0%) | $1.38B(+4.0%) |
| Sep 2005 | - | $285.00M(+8.4%) | $1.33B(-0.9%) |
| Jun 2005 | - | $263.00M(+18.5%) | $1.34B(-4.5%) |
| Mar 2005 | - | $222.00M(-60.1%) | $1.40B(-2.6%) |
| Dec 2004 | $1.44B(-6.7%) | $557.00M(+87.5%) | $1.44B(-10.0%) |
| Sep 2004 | - | $297.00M(-8.9%) | $1.60B(-0.9%) |
| Jun 2004 | - | $326.00M(+25.9%) | $1.61B(+1.9%) |
| Mar 2004 | - | $259.00M(-63.9%) | $1.58B(+2.6%) |
| Dec 2003 | $1.54B(+33.2%) | $717.00M(+130.5%) | $1.54B(+86.8%) |
| Sep 2003 | - | $311.00M(+5.1%) | $826.00M(+60.4%) |
| Jun 2003 | - | $296.00M(+35.2%) | $515.00M(+135.2%) |
| Mar 2003 | - | $219.00M | $219.00M |
| Dec 2002 | $1.16B(-16.1%) | - | - |
| Dec 2001 | $1.38B(+64.8%) | - | - |
| Dec 2000 | $838.00M(-2.7%) | - | - |
| Dec 1999 | $861.00M(-24.9%) | - | - |
| Dec 1998 | $1.15B | - | - |
FAQ
- What is Novartis AG annual capital expenditures?
- What is the all time high annual CAPEX for Novartis AG?
- What is Novartis AG annual CAPEX year-on-year change?
- What is Novartis AG quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Novartis AG?
- What is Novartis AG quarterly CAPEX year-on-year change?
- What is Novartis AG TTM capital expenditures?
- What is the all time high TTM CAPEX for Novartis AG?
- What is Novartis AG TTM CAPEX year-on-year change?
What is Novartis AG annual capital expenditures?
The current annual CAPEX of NVS is $3.81B
What is the all time high annual CAPEX for Novartis AG?
Novartis AG all-time high annual capital expenditures is $3.81B
What is Novartis AG annual CAPEX year-on-year change?
Over the past year, NVS annual capital expenditures has changed by +$1.06B (+38.54%)
What is Novartis AG quarterly capital expenditures?
The current quarterly CAPEX of NVS is $1.13B
What is the all time high quarterly CAPEX for Novartis AG?
Novartis AG all-time high quarterly capital expenditures is $1.34B
What is Novartis AG quarterly CAPEX year-on-year change?
Over the past year, NVS quarterly capital expenditures has changed by +$403.00M (+55.36%)
What is Novartis AG TTM capital expenditures?
The current TTM CAPEX of NVS is $3.81B
What is the all time high TTM CAPEX for Novartis AG?
Novartis AG all-time high TTM capital expenditures is $3.81B
What is Novartis AG TTM CAPEX year-on-year change?
Over the past year, NVS TTM capital expenditures has changed by +$464.00M (+13.85%)